Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
BALPHARMA

Bal Pharma Share Price

 

 

Bal Pharma live price: ₹78.18. It opened at ₹78 vs previous close ₹78; intraday high/low: ₹79/₹76. The 50 & 200 DMA stand at ₹72.55/₹80.14.

Bal Pharma Performance

  • Today's Low
  • ₹76
  • Today's High
  • ₹79
  • 52 Week Low
  • ₹60
  • 52 Week High
  • ₹117
  • Open Price₹78
  • Previous Close₹78
  • Volume1,938
  • 50 DMA₹72.55
  • 100 DMA₹74.19
  • 200 DMA₹80.14

Bal Pharma Chart

Investment Returns

  • Over 1 Month + 15.14%
  • Over 3 Month + 13.88%
  • Over 6 Month -3.84%
  • Over 1 Year -26.25%

Smart Investing Starts Here Start SIP with Bal Pharma for Steady Growth!

Invest Now

Bal Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 15.3
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 125
  • P/B Ratio
  • 1.6
  • Average True Range
  • 3.56
  • EPS
  • 5.1
  • Dividend Yield
  • 1.5
  • MACD Signal
  • 1.28
  • RSI
  • 64.14
  • MFI
  • 68.07

Bal Pharma Financials

Bal Pharma Technicals

EMA & SMA

Current Price
₹78.18
+ 0.59 (0.76%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹73.84
  • 50 Day
  • ₹72.55
  • 100 Day
  • ₹74.19
  • 200 Day
  • ₹80.14

Resistance and Support

77.74 Pivot Speed
  • R3 82.39
  • R2 80.69
  • R1 79.44
  • S1 76.49
  • S2 74.79
  • S3 73.54

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Bal Pharma has an operating revenue of Rs. 309.46 Cr. on a trailing 12-month basis. An annual revenue de-growth of -11% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 41%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 7% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 4% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 48 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 65 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Bal Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-11 Quarterly Results, ESOP & A.G.M.
2025-05-29 Audited Results & Dividend
2025-02-13 Quarterly Results & Fund Raising
Date Purpose Remarks
2025-09-18 FINAL Rs.1.20 per share(12%)Dividend
View Bal Pharma Dividend History Arrow

Bal Pharma F&O

Bal Pharma Shareholding Pattern

50.86%
0.14%
32.84%
16.16%

Bal Pharma FAQs

Bal Pharma share price is ₹78 As on 23 April, 2026 | 03:55

The Market Cap of Bal Pharma is ₹124.5 Cr As on 23 April, 2026 | 03:55

The P/E ratio of Bal Pharma is 15.3 As on 23 April, 2026 | 03:55

The PB ratio of Bal Pharma is 1.6 As on 23 April, 2026 | 03:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23